Effects of bovine lactoferrin on the growth and biofilm formation of Escherichia coli and Klebsiella pneumoniae associated with bovine mastitis Authors: Rin Furukido, Yuzo Kurokawa, Naoki Isobe, Naoki Suzuki Published: 2026 ABSTRACT AbstractEscherichia coli and Klebsiella pneumoniae are major causal pathogens of mastitis in dairy cows. In this study, we focus on bovine lactoferrin, an endogenous protein with antimicrobial and antibiofilm activities expressed in mammary glands. Given that the activity of lactoferrin against bovine mastitis-associated pathogens has yet to be fully elucidated, we sought to determine its effects on the growth and biofilm formation of E. coli and K. pneumoniae. We selected 24 and 20 isolates of E. coli and K. pneumoniae, respectively, including mastitis- and environmentally derived isolates, and examined the antimicrobial and antibiofilm effects of lactoferrin using a microdilution method and crystal violet staining, respectively. The percentages of E. coli and K. pneumoniae isolates for which we obtained lactoferrin minimum inhibitory concentration ≥ 4,000 µg/mL were 57% and 80%, respectively. At concentrations of 200 and 1,000 µg/mL, although lactoferrin caused significant reductions in the growth of both E. coli and K. pneumoniae, whereas biofilm formation by K. pneumoniae was inhibited, that of E. coli was paradoxically enhanced. These findings highlight that E. coli and K. pneumoniae, which have traditionally been grouped as coliforms in the context of bovine mastitis, have distinct responses when exposed to lactoferrin.Keywords: Escherichia coli, Klebsiella pneumoniae, Lactoferrin, Biofilm, Bovine mastitis Introduction Mastitis is among the most common diseases of dairy cows, causing economic losses due to milk wastage and treatment cost (Heikkilä et al. 2018). Escherichia coli and Klebsiella pneumoniae within the bacterial family Enterobacteriaceae, are considered representative species causing environmental mastitis (Oliveira et al. 2013; Morales-Ubaldo et al. 2023). Within the framework of dairy herd management, E. coli and K. pneumoniae are categorized as “coliforms” and are typically prevalent in feces and heavily contaminated organic bedding materials, feed, and soil. Current control measures focus largely on reducing the contamination of bedding materials (Hogan and Larry Smith, 2003). Gram-negative bacteria, particularly coliforms, are estimated to account for approximately 25–40% of clinical mastitis cases (Schukken et al. 2012). To control mastitis, antimicrobial agents are used during both the lactation and dry periods (Ruegg 2017), and given that new mammary gland infections frequently occur immediately after dry-off, antibiotic dry-cow therapy has been implemented (Ruegg 2017). Despite these control measures, new infections still occur after the dry-off period, likely due to reduced antimicrobial efficacy over time, partly associated with pharmacokinetic limitations and subtherapeutic drug concentrations (Ban‑Cucerzan et al., 2026) and bacterial persistence mechanisms such as biofilm formation, which reduces antimicrobial susceptibility and contributes to treatment failure (Pedersen et al. 2021). In addition, antimicrobial resistance among zoonotic pathogens and those infecting food-producing livestock presents notable One Health challenges (Lee et al. 2022). Given growing concerns regarding such antimicrobial resistance, there is an urgent need to develop dry cow management strategies that are independent of antimicrobial usage (Li et al. 2023; Winder et al. 2019). Lactoferrin, an iron-binding glycoprotein abundant in milk, has been established to have antimicrobial activity, including bacteriostatic and bactericidal effects, primarily through sequestration of iron, which is essential for bacterial growth (Valenti et al. 2004). In the dairy cows, previous findings have indicated that lactoferrin is particularly important for maintaining udder hygiene during the dry period (Vilar and Rajala-Schultz 2020). Moreover, the findings that milking management practices can influence lactoferrin concentrations further highlights its relevance (Suzuki et al. 2024; Isobe 2017). It has also been reported that lactoferrin has antibiofilm efficacy (Valenti et al. 2004), which, given that biofilms hamper the penetration of antimicrobial agents, can result in delays in the complete cure of mastitis, and is of potentially considerable value (Pedersen et al. 2021). In addition, biofilms can contribute to the horizontal transmission of antimicrobial resistant genes and hence the spread of antimicrobial-resistant bacteria (Abe et al. 2020). With respect to bovine mastitis, it has been suggested that the capacity of E. coli to form biofilms on mammary tissue, and thereby acquire antimicrobial resistance, may explain the recurrence of mastitis (Goulart and Mellata 2022). On the basis of the findings of studies that have investigated the relationship between lactoferrin and biofilm formation, it has been established that 95% to 98% of E. coli and 100% of K. pneumoniae biofilms are reduced in extent following 1 h of lactoferrin treatment (Sheffield et al. 2012). It has also been reported that lactoferrin inhibits biofilm formation among enteroaggregative E. coli (EAEC) (Ochoa et al. 2006). In contrast, Ojima et al. (2016) have reported that the presence of lactoferrin enhances the biofilm-forming capacity of the E. coli K-12 laboratory strain. Consequently, there remains a lack of consensus regarding the effects of lactoferrin on biofilm formation among bacteria in the Enterobacteriaceae, and our knowledge regarding how lactoferrin influences the capacity of mastitis‑causing pathogens to form biofilms remains particularly limited. Given the imperative to reduce the current dependence on antimicrobial agents, it is essential to clarify how the antimicrobial and anti‑biofilm potentials of lactoferrin influence the activities of mastitis‑causing pathogens. In this study, we accordingly sought to determine changes in the growth and biofilm formation capacities of the major environmental mastitis pathogens E. coli and K. pneumoniae as a function of lactoferrin concentration. Materials and methods Bacterial isolates For the purposes of this study, we used 44 E. coli and K. pneumoniae isolates isolated from mastitic cows and the environment [24 E. coli isolates (nine mastitis-related and 15 environmental) and 20 K. pneumoniae isolates (nine mastitis-related and 11 environmental)]. Mastitis-related isolates were collected from clinical cases of mastitis, defined based on a range of clinical signs, such as redness in the affected parts or the complete udder; warmth, swelling, and pain upon touch; the denatured states of the milk samples; milk clots; and discoloration and changes in the consistency of milk (Sharun et al. 2021) and were considered to represent the primary causative agents of infection. Environmental isolates were obtained from dairy cow bedding collected from farms in Hiroshima Prefecture. Minimal inhibitory concentrations of lactoferrin The minimal inhibitory concentrations (MIC) of lactoferrin against the assessed isolates were determined using a previously described broth microdilution method (Kawai et al. 2007). Stored bacteria were cultured overnight on trypticase soy agar (TSA) (Eiken Chemical Co., Ltd, Japan). The colonies were suspended in sterile phosphate-buffered saline (PBS), with the concentration of the bacterial suspension being adjusted to 1 × 108 colony-forming units (CFU)/mL. PBS was prepared in-house using a standard formulation. MIC was estimated turbidimetrically in 96-well microplates. Lactoferrin (Fujifilm Wako Pure Chemical Corp., Japan) was added to Mueller–Hinton broth (Benton, Dickinson and Co., USA), and bacterial suspensions and lactoferrin solutions were added to the wells to give final concentrations of 104 CFU/mL bacteria and 7.8–4,000 µg/mL lactoferrin, prepared by serial two-fold dilution. The plates were incubated overnight at 37 °C. Biofilm assay using lactoferrin Stored bacteria were cultured on TSA overnight, and the resulting colonies were suspended in Mueller–Hinton broth. The turbidity of bacterial suspensions, estimated based on comparisons with 0.5–1.0 McFarland standards, was adjusted to that corresponding to 2 × 107 CFU/mL. Biofilm formation was quantified based on the crystal violet method (ELISA Plate S; Sumitomo Bakelite Co., Ltd, Japan), as previously described (Neumann et al. 2023; Kamble et al. 2022; Hu et al. 2022; Niu and Gilbert 2004). In the test wells, 100 µL of Mueller–Hinton broth containing lactoferrin was mixed with the bacterial suspension, whereas in the control wells, 100 µl Mueller–Hinton broth without lactoferrin was mixed with the bacterial suspension. The final concentration of bacteria was adjusted to 1 × 10⁷ CFU/mL, and the final concentrations of lactoferrin were 0 (control), 200, and 1,000 µg/mL. The plates were incubated overnight at 37 °C. Following incubation, to determine bacterial growth, the optical density (OD) of well contents was measured spectrophotometrically at 600 nm (OD600) (Multiskan Skyhigh Plate Reader; Thermo Fisher Scientific, Japan). Having thereafter discarded the bacterial suspensions and washed the plate wells three times with 200 µL of PBS, 200 µL of methanol was added to fix the attached biofilms for 15 min, and after discarding the methanol and drying the plates, 200 µL of 0.1% crystal violet was added and allowed to stand for 30 min to stain the biofilms. Thereafter, having discarded the stain, the wells were washed three times with PBS, the plates were thoroughly dried, and 150 µL of 33% acetic acid was added, followed by shaking for 5 min. The ODs of well contents were then measured spectrophotometrically at 570 nm (OD570). Biofilm formation capacities were thereafter determined dividing the OD values obtained 570 nm by those recorded at 600 nm (OD570/OD600), as described by Lu et al. (2021). Statistical analysis Statistical analyses were performed using JMP Pro version 18 (SAS Institute, Cary, NC, USA). Generalized linear mixed models were used to analyze OD600, OD570, and OD570/OD600 values separately, with lactoferrin concentration as a fixed effect and bacterial isolates as a random effect. Post hoc comparisons were conducted using Tukey’s test to assess pairwise differences among treatment groups. A significance level of p < 0.05 was applied. Results Minimum inhibitory concentrations of lactoferrin For E. coli, 57% of the isolates grew even at the highest lactoferrin concentration tested (4,000 µg/mL), whereas the remaining isolates showed MIC values below 250 µg/mL (Fig. 1A). In contrast, for K. pneumoniae, 80% of the isolates grew at 4,000 µg/mL lactoferrin, while one isolate each exhibited MICs of 250 µg/mL and 500 µg/mL, respectively (Fig. 1B). With respect to bacterial origin, for both bacterial species, we detected no significant differences between the MIC values obtained for mastitis and environmental isolates (Fig. 1C and D). Distribution of the minimum inhibitory concentrations (MIC) of lactoferrin for Escherichia coli and Klebsiella pneumoniae. Panels A and B show the E. coli and K. pneumoniae isolates used in this study, respectively. Panels C and D show comparisons of E. coli and K. pneumoniae with respect to origin, environment, and bovine mastitis Relationships between biofilm concentration and bacterial growth, and biofilm formation For E. coli, OD600 values in the medium containing 1,000 µg/mL lactoferrin were significantly lower than those in the medium without lactoferrin and with 200 µg/mL lactoferrin (Fig. 2A). Similarly, for K. pneumoniae, OD600 values at 1,000 µg/mL lactoferrin were significantly lower than those in the medium without lactoferrin and with 200 µg/mL lactoferrin (Fig. 3A). Notably, for E. coli and K. pneumoniae, we recorded significantly lower and higher OD570 values, respectively, in medium without lactoferrin and in the 200 and 1,000 mg/mL lactoferrin treatment medium (Figs. 2B and 3B, respectively). Moreover, in E. coli, biofilm formation capacity (OD570/OD600) in medium without lactoferrin was significantly lower than that in the presence of 200 and 1,000 µg/mL lactoferrin (Fig. 2C). In contrast, in K. pneumoniae, biofilm formation in the presence of 200 µg/mL lactoferrin was significantly lower than that in the absence of lactoferrin and in the presence of 1,000 µg/mL lactoferrin (Fig. 3C). Absorbance values [OD600: bacterial growth (A); OD570: biofilm formation amount (B), and OD570/OD600: biofilm formation capacity (C)] obtained for 24 Escherichia coli isolates. Dot plots and horizontal bars represent one value per isolate and the least square mean, respectively Absorbance values [OD600: bacterial growth (A); OD570: biofilm formation amount (B), and OD570/OD600: biofilm formation capacity (C)] obtained for 20 Klebsiella pneumoniae isolates. Dot plots and horizontal bars represent one value per isolate and the least square mean, respectively Discussion It has been reported that in clinically healthy cows, the concentrations of lactoferrin in milk can range between 100 and 350 µg/mL. However, during the dry-off period lactoferrin concentrations in milk can reach levels of between 400 and 1,050 µg/mL and rise to 3,600 µg/mL in cases of clinical mastitis (Newman et al. 2009). On the basis of our findings in this study, it would appear that the concentrations of lactoferrin in bovine milk are not sufficient to completely inhibit the growth of E. coli and K. pneumoniae. Moreover, given the presence of other antimicrobial components in bovine mammary glands, such as lingual antimicrobial peptide, S100A7, and cathelicidin (Isobe 2017; Suzuki et al. 2024), it would be also necessary to determine the effects of these components on pathogenic bacteria. Furthermore, it has been reported that E. coli and K. pneumoniae harbor the fecA gene, which is associated with the uptake of ferric citrate (Furukido et al. 2025). Therefore, bacterial growth in milk may be achieved through bacterial virulence factors regardless of the concentration of lactoferrin present in milk. Although the effects of lactoferrin on the biofilm formation of E. coli have yet to be sufficiently determined, our findings in this study provide evidence to indicate that exposure to lactoferrin may contribute to enhancing the biofilm‑forming capacity of mastitis‑associated E. coli isolates present on dairy farms. Whereas this appears to contrast with the previously reported antibiofilm activity of lactoferrin against EAEC bacteria (Ochoa et al. 2006), we speculate that this discrepancy could be explained by the fact that in EAEC, lactoferrin contributes to the degradation of aggregating adherent fimbriae (AAF)-II, thereby reducing biofilm formation (Ochoa et al. 2006). As AAF-II is a pathogenic factor characteristic of EAEC (Van Nederveen and Melton-Celsa 2025) biofilm formation by other E. coli may not be inhibited by lactoferrin. However, the specific factors associated with mammary pathogenicity have not yet been fully identified, and the virulence characteristics of the isolates used in this study have not been comprehensively clarified. Therefore, further studies are required to elucidate the mechanisms underlying the enhancement of biofilm formation in the presence of lactoferrin. In contrast to E. coli, biofilm formation of K. pneumoniae was reduced in the presence of lactoferrin, particularly at 200 µg/mL, whereas bacterial growth was not decreased at this concentration. Biofilm biomass (OD570) of K. pneumoniae was reduced in the presence of 200 µg/mL and 1,000 µg/mL lactoferrin compared with the untreated control (Fig. 3B). However, at 1,000 µg/mL, bacterial growth was also suppressed (Fig. 3A). Therefore, the biofilm formation capacity expressed as OD570/OD600 was comparable to that of the untreated control. These results suggest that the reduction in OD570 observed at 200 µg/mL reflects a decrease in biofilm formation capacity, whereas the reduction observed at 1,000 µg/mL is likely attributable to impaired bacterial growth. In addition, we suspect that this differential susceptibility is associated with the different biofilm formation capacities of these two bacterial species. In this regard, it has been reported that biofilms comprise a range of extracellular macromolecular substances, including polysaccharides, proteins, nucleic acids, lipids, and extracellular DNA (Flemming et al. 2023), the compositions of which differ among different bacterial species and strains (Saharan et al. 2024). This accordingly highlights the importance of further studies to gain a better understanding of the formation mechanisms and constituents of bacterial biofilms. A key strength of this study is that we clearly demonstrate species‑specific differences in how E. coli and K. pneumoniae respond to bovine lactoferrin, revealing distinct biofilm and growth behaviors that raise questions regarding the traditional practice of treating these organisms uniformly as “coliforms.” However, despite these important findings, certain limitations of this study should be acknowledged. Firstly, although crystal violet staining confirmed increases in biofilm production, this method is unable to distinguish whether such increases represent greater cellular biomass or enhanced extracellular matrix production. Therefore, direct microscopic evaluation (e.g., confocal laser scanning microscopy or electron microscopy) is essential to fully elucidate the structural impact of lactoferrin, and such detailed visualization remains an indispensable requirement for future investigations to clarify these biofilm characteristics. Secondly, the use of overnight assays and OD-based metrics limits insights into the temporal and mechanistic aspects of lactoferrin-dependent biofilm modulation, as measurements were restricted to a single time point and do not account for potential adaptive responses under prolonged exposure. Finally, although the number of isolates analyzed was practical, these isolates may not be representative of the full diversity of environmental and mastitis‑associated isolates. Accordingly, these factors should be considered when interpreting the observed species‑specific responses. In conclusion, in this study, we revealed that E. coli and K. pneumoniae show clearly different growth and biofilm responses to bovine lactoferrin, highlighting species‑specific traits that have been overlooked within the conventional “coliform” classification. These in vitro findings will provide an important basis for reconsidering how innate immune components may differentially shape the ecology of major environmental mastitis pathogens. While the use of exogenous lactoferrin at high concentrations may raise economic concerns, this study primarily considers lactoferrin as a natural antimicrobial component present in milk. Therefore, the findings are more relevant to understanding bacterial adaptation to host-derived antimicrobial components than to evaluating its practical application. Although further validation under more complex conditions is needed, the species‑specific responses identified herein provide valuable insights that may inform future research and ultimately contribute to more refined approaches for the control of mastitis. Author contributions All authors contributed to the study conception and design. **Rin Furukido** : Conceptualization, Data curation, Formal analysis, Methodology, Visualization, and Writing–original draft. **Yuzo Kurokawa** : Writing–review and editing. **Naoki Isobe** : Writing–review and editing. **Naoki Suzuki** : Conceptualization, Data curation, Formal analysis, Funding acquisition, Methodology, Project administration, Resources, Validation, Visualization and Writing–review and editing. Funding Open Access funding provided by Hiroshima University. This work was supported by the Japan Society for the Promotion of Science (Tokyo, Japan) Grants-in- Aid for Scientific Research (grant numbers: 24K18003; grant name: KAKENHI) conferred to Naoki Suzuki. Data availability The datasets analyzed during the current study are available from the corresponding author on reasonable request. Declaration Ethics approval No experiments involving humans or animals were conducted during this study. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Refferences Associated Data Data Availability Statement The datasets analyzed during the current study are available from the corresponding author on reasonable request.